{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:25:50Z","timestamp":1787660750904,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease [CKD] is associated with profound alterations of both gut microbiota composition and functions, commonly referred to as gut dysbiosis. These changes are driven by several factors such as dietary restrictions, medications, and uremia, which further contribute to patients with CKD to their pro-inflammatory and immunocompromised state. Recent evidence suggests that dysbiosis may also increase susceptibility to infections, which remain a leading cause of morbidity and mortality in CKD patients. In this review, we aimed at examining the features of the altered gut microbiome in patients with CKD, its potential role in promoting infection risk, and current therapeutic strategies targeting the gut microbiota to mitigate CKD-related complications.<\/jats:p>","DOI":"10.1007\/s11255-026-05061-z","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:45:07Z","timestamp":1772624707000},"page":"3759-3770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Microbiome alterations and their potential impact on infection risk in chronic kidney disease and end-stage kidney disease: a narrative review"],"prefix":"10.1007","volume":"58","author":[{"given":"Lucia Federica","family":"Stefanelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Cattarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Katiana","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorella","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buscaglion","family":"Pierantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Nalesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mazzitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"5061_CR1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322:1294\u20131304","journal-title":"JAMA"},{"issue":"6S1","key":"5061_CR2","doi-asserted-by":"publisher","first-page":"A8","DOI":"10.1053\/j.ajkd.2025.02.602","volume":"85","author":"KL Johansen","year":"2025","unstructured":"Johansen KL, Gilbertson DT, Li S, Li S, Liu J, Roetker NS, Hart A, Knapp CD, Ku E, Powe NR, Snyder J, Peter WS, Weinhandl ED, Wetmore JB (2025) US renal data system 2024 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 85(6S1):A8\u2013A11","journal-title":"Am J Kidney Dis"},{"key":"5061_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00467-016-3392-7","volume":"32","author":"S Al Khodor","year":"2017","unstructured":"Al Khodor S, Shatat IF (2017) Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol 32:921\u2013931","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"5061_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/MNH.0000000000000661","volume":"30","author":"K Sumida","year":"2021","unstructured":"Sumida K, Lau WL, Kovesdy CP, Kalantar-Zadeh K, Kalantar-Zadeh K (2021) Microbiome modulation as a novel therapeutic approach in chronic kidney disease. Curr Opin Nephrol Hypertens 30(1):75\u201384","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"5061_CR5","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s11255-019-02291-2","volume":"51","author":"C Plata","year":"2019","unstructured":"Plata C, Cruz C, Cervantes LG, Ramirez V (2019) The gut microbiota and its relationship with chronic kidney disease. Int Urol Nephrol 51:2209\u20132226","journal-title":"Int Urol Nephrol"},{"key":"5061_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","volume":"24","author":"J Gilbert","year":"2018","unstructured":"Gilbert J, Blaser MJ, Caporaso JG, Jansson J, Lynch SV, Knight R (2018) Current understanding of the human microbiome. Nat Med 24:392\u2013400","journal-title":"Nat Med"},{"key":"5061_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.7150\/ijbs.37421","volume":"16","author":"I-W Wu","year":"2020","unstructured":"Wu I-W, Lin C-Y, Chang L-C, Lee C-C, Chiu C-Y, Hsu H-J et al (2020) Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxin levels in chronic kidney disease: discovery and validation study. Int J Biol Sci 16:420\u2013434","journal-title":"Int J Biol Sci"},{"issue":"2","key":"5061_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ekir.2019.11.002","volume":"5","author":"K Sumida","year":"2020","unstructured":"Sumida K, Yamagata K, Kovesdy CP (2020) Constipation in CKD. Kidney Int Rep 5(2):121\u2013134","journal-title":"Kidney Int Rep"},{"issue":"3","key":"5061_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1124\/jpet.118.251389","volume":"367","author":"WL Lau","year":"2018","unstructured":"Lau WL, Vaziri ND, Nunes ACF et al (2018) The phosphate binder Ferric Citrate alters the gut microbiome in rats with chronic kidney disease. J Pharmacol Exp Ther 367(3):452\u2013460","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"5061_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ncp.10662","volume":"37","author":"M Ribeiro","year":"2022","unstructured":"Ribeiro M, Fonseca L, Anjos JS et al (2022) Oral iron supplementation in patients with chronic kidney disease: can it be harmful to the gut microbiota? Nutr Clin Pract 37(1):81\u201393","journal-title":"Nutr Clin Pract"},{"key":"5061_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5500\/wjt.v14.i1.90194","volume":"14","author":"M Salvadori","year":"2024","unstructured":"Salvadori M, Rosso G (2024) Update on the reciprocal interference between immunosuppressive therapy and gut microbiota after kidney transplantation. World J Transplant 14:90\u2013194","journal-title":"World J Transplant"},{"issue":"Pt 11","key":"5061_CR12","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","volume":"156","author":"C Jernberg","year":"2010","unstructured":"Jernberg C, Lofmark S, Edlund C, Jansson JK (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156(Pt 11):3216\u20133223","journal-title":"Microbiology"},{"issue":"2","key":"5061_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF01307542","volume":"38","author":"JY Kang","year":"1993","unstructured":"Kang JY (1993) The gastrointestinal tract in uremia. Dig Dis Sci 38(2):257\u2013268","journal-title":"Dig Dis Sci"},{"issue":"5","key":"5061_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1042\/CS20171107","volume":"132","author":"WL Lau","year":"2018","unstructured":"Lau WL, Savoj J, Nakata MB, Vaziri ND (2018) Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin Sci 132(5):509\u2013522","journal-title":"Clin Sci"},{"issue":"6","key":"5061_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1177\/08968608211051809","volume":"42","author":"D Chang","year":"2022","unstructured":"Chang D, Xu X, Yang Z, Ma T, Nie J, Dong J (2022) Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis. Perit Dial Int 42(6):622\u2013630. https:\/\/doi.org\/10.1177\/08968608211051809","journal-title":"Perit Dial Int"},{"issue":"20","key":"5061_CR16","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.3390\/nu16203494","volume":"16","author":"A Matar","year":"2024","unstructured":"Matar A, Damianos JA, Jencks KJ, Camilleri M (2024) Intestinal Barrier Impairment, Preservation, and Repair: An Update. Nutrients 16(20):3494","journal-title":"Nutrients"},{"issue":"4","key":"5061_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/14787210.2021.1834847","volume":"19","author":"K Brandenburg","year":"2021","unstructured":"Brandenburg K, Schromm AB, Weindl G, Heinbockel L, Correa W, Mauss K, de Martinez Tejada G, Garidel P (2021) An update on endotoxin neutralization strategies in Gram-negative bacterial infections. Expert Rev Anti-Infect Ther 19(4):495\u2013517","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"1","key":"5061_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1681\/ASN.2015111285","volume":"28","author":"K Andersen","year":"2017","unstructured":"Andersen K, Kesper MS, Marschner JA et al (2017) Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation. J Am Soc Nephrol 28(1):76\u201383","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"5061_CR19","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s10620-012-2242-0","volume":"57","author":"F Wang","year":"2012","unstructured":"Wang F, Zhang P, Jiang H, Cheng S (2012) Gut bacterial translocation contributes to microinflammation in experimental uremia. Dig Dis Sci 57(11):2856\u20132862","journal-title":"Dig Dis Sci"},{"issue":"5","key":"5061_CR20","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.4049\/jimmunol.176.5.3070","volume":"176","author":"MD Neal","year":"2006","unstructured":"Neal MD, Leaphart C, Levy R et al (2006) Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 176(5):3070\u20133079","journal-title":"J Immunol"},{"issue":"9","key":"5061_CR21","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10620-014-3202-7","volume":"59","author":"K Shi","year":"2014","unstructured":"Shi K, Wang F, Jiang H et al (2014) Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig Dis Sci 59(9):2109\u20132117","journal-title":"Dig Dis Sci"},{"issue":"1","key":"5061_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2215\/CJN.04610510","volume":"6","author":"CW McIntyre","year":"2011","unstructured":"McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK (2011) Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 6(1):133\u2013141","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"5061_CR23","doi-asserted-by":"publisher","first-page":"F1211","DOI":"10.1152\/ajprenal.00298.2018","volume":"316","author":"GP Hobby","year":"2019","unstructured":"Hobby GP, Karaduta O, Dusio GF, Singh M, Zybailov BL, Arthur JM (2019) Chronic kidney disease and the gut microbiome. Am J Physiol Renal Physiol 316(6):F1211\u2013F1217. https:\/\/doi.org\/10.1152\/ajprenal.00298.2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"5061_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/metabo1005018","volume":"10","author":"KA Lee-Sarwar","year":"2020","unstructured":"Lee-Sarwar KA, Lasky-Su J, Kelly RS, Litonjua AA, Weiss ST (2020) Metabolome-microbiome crosstalk and human disease. Metabolites 10(5):181. https:\/\/doi.org\/10.3390\/metabo1005018","journal-title":"Metabolites"},{"issue":"12","key":"5061_CR25","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1093\/ndt\/gfm414","volume":"22","author":"MD Navarro","year":"2007","unstructured":"Navarro MD, Carracedo J, Ram\u00edrez R, Madue\u00f1o JA, Merino A, Rodr\u00edguez M, Mart\u00edn-Malo A, Aljama P (2007) Bacterial DNA prolongs the survival of inflamed mononuclear cells in haemodialysis patients. Nephrol Dial Transplant 22(12):3580\u20133585","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"5061_CR26","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1093\/ndt\/gfn308","volume":"23","author":"A Merino","year":"2008","unstructured":"Merino A, Nogueras S, Garc\u00eda-Maceira T, Rodr\u00edguez M, Martin-Malo A, Ramirez R, Carracedo J, Aljama P (2008) Bacterial DNA and endothelial damage in haemodialysis patients. Nephrol Dial Transplant 23(11):3635\u20133642","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"5061_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.2215\/CJN.12161018","volume":"14","author":"NB Shah","year":"2019","unstructured":"Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S, Lelouvier B, Servant F, Serena G, Thadhani RI, Raj DS, Fasano A (2019) Blood Microbiome Profile in CKD: A Pilot Study. Clin J Am Soc Nephrol 14(5):692\u2013701","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"5061_CR28","doi-asserted-by":"publisher","first-page":"892232","DOI":"10.3389\/fcimb.2022.892232","volume":"3","author":"K Sumida","year":"2022","unstructured":"Sumida K, Han Z, Chiu CY, Mims TS, Bajwa A, Demmer RT, Datta S, Kovesdy CP, Pierre JF (2022) Circulating Microbiota in Cardiometabolic Disease. Front Cell Infect Microbiol 3(12):892232","journal-title":"Front Cell Infect Microbiol"},{"key":"5061_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu12041007","author":"KE Adair","year":"2020","unstructured":"Adair KE, Bowden RG (2020) Ameliorating chronic kidney disease using a whole food plant-based diet. Nutrients. https:\/\/doi.org\/10.3390\/nu12041007","journal-title":"Nutrients"},{"key":"5061_CR30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.2215\/CJN.12491211","volume":"7","author":"KP Patel","year":"2012","unstructured":"Patel KP, Luo FJ, Plummer NS et al (2012) The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol 7:982\u2013988","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"5061_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2215\/CJN.12391018","volume":"14","author":"H Kim","year":"2019","unstructured":"Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Grams ME, Coresh J, Rebholz CM (2019) Plant-Based Diets and Incident CKD and Kidney Function. Clin J Am Soc Nephrol 14(5):682\u2013691","journal-title":"Clin J Am Soc Nephrol"},{"issue":"16","key":"5061_CR32","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.7150\/ijms.66451","volume":"18","author":"CK Hsu","year":"2021","unstructured":"Hsu CK, Su SC, Chang LC, Shao SC, Yang KJ, Chen CY, Chen YT, Wu IW (2021) Effects of Low Protein Diet on Modulating Gut Microbiota in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of International Studies. Int J Med Sci 18(16):3839\u20133850","journal-title":"Int J Med Sci"},{"issue":"5","key":"5061_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2215\/CJN.0000000682","volume":"20","author":"J Stanford","year":"2025","unstructured":"Stanford J, Stefoska-Needham A, Jiang X, McWhinney B, Hassan HIC, El-Omar E, Charlton K, Lambert K (2025) High-Diversity Plant-Based Diet and Gut Microbiome, Plasma Metabolome, and Symptoms in Adults with CKD. Clin J Am Soc Nephrol 20(5):619\u2013631","journal-title":"Clin J Am Soc Nephrol"},{"key":"5061_CR34","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.3390\/nu11123006","volume":"11","author":"S Lai","year":"2019","unstructured":"Lai S, Molfino A, Testorio M et al (2019) Effect of low-protein diet and inulin on microbiota and clinical parameters in patients with chronic kidney disease. Nutrients 11:3006","journal-title":"Nutrients"},{"key":"5061_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1053\/j.jrn.2017.11.007","volume":"28","author":"AP Black","year":"2018","unstructured":"Black AP, Anjos JS, Cardozo L et al (2018) Does low-protein diet influence the uremic toxin serum levels from the gut microbiota in nondialysis chronic kidney disease patients? J Ren Nutr 28:208\u2013214","journal-title":"J Ren Nutr"},{"issue":"9","key":"5061_CR36","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3390\/nu17091438","volume":"17","author":"FK Martino","year":"2025","unstructured":"Martino FK, Stefanelli LF, Zattarin A, Lovato Correa Dias L, Redi G, Khalf R, Del Prete D, Nalesso F (2025) Protein counting as an educational strategy to optimize low-protein-diet adherence and satisfaction in stage 4 and 5 chronic kidney disease patients: a pilot study. Nutrients 17(9):1438","journal-title":"Nutrients"},{"issue":"8","key":"5061_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506\u2013514","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1\u20133","key":"5061_CR38","first-page":"92","volume":"22","author":"ML Simenhoff","year":"1996","unstructured":"Simenhoff ML, Dunn SR, Zollner GP, Fitzpatrick ME, Emery SM, Sandine WE et al (1996) Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried lactobacillus acidophilus. Miner Electrolyte Metab 22(1\u20133):92\u201396","journal-title":"Miner Electrolyte Metab"},{"issue":"3 Suppl 1","key":"5061_CR39","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1053\/ajkd.2003.50104","volume":"41","author":"F Takayama","year":"2003","unstructured":"Takayama F, Taki K, Niwa T (2003) Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am J Kidney Dis 41(3 Suppl 1):S142\u2013S145","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5061_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.jrn.2004.09.028","volume":"15","author":"K Taki","year":"2005","unstructured":"Taki K, Takayama F, Niwa T (2005) Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients. J Ren Nutr 15(1):77\u201380","journal-title":"J Ren Nutr"},{"key":"5061_CR41","doi-asserted-by":"publisher","first-page":"568571","DOI":"10.1155\/2014\/568571","volume":"2014","author":"R Natarajan","year":"2014","unstructured":"Natarajan R, Pechenyak B, Vyas U, Ranganathan P, Weinberg A, Liang P et al (2014) Randomized controlled trial of strain-specific probiotic formulation [Renadyl] in dialysis patients. Biomed Res Int 2014:568571","journal-title":"Biomed Res Int"},{"issue":"4","key":"5061_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3920\/BM2014.0088","volume":"6","author":"IK Wang","year":"2015","unstructured":"Wang IK, Wu YY, Yang YF, Ting IW, Lin CC, Yen TH et al (2015) The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebocontrolled trial. Benef Microbes 6(4):423\u2013430","journal-title":"Benef Microbes"},{"issue":"9","key":"5061_CR43","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s12325-010-0059-9","volume":"27","author":"N Ranganathan","year":"2010","unstructured":"Ranganathan N, Ranganathan P, Friedman EA, Joseph A, Delano B, Goldfarb DS et al (2010) Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 27(9):634\u2013647","journal-title":"Adv Ther"},{"issue":"4763\u20134770","key":"5061_CR44","first-page":"73","volume":"9","author":"A Mafi","year":"2018","unstructured":"Mafi A, Namazi G, Soleimani A, Bahmani F, Aghadavod E, Asemi Z (2018) Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Food Funct 9(4763\u20134770):73","journal-title":"Food Funct"},{"issue":"6S","key":"5061_CR45","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1053\/j.jrn.2022.12.004","volume":"33","author":"K Lambert","year":"2023","unstructured":"Lambert K, Rinninella E, Biruete A, Sumida K, Stanford J, Raoul P, Mele MC, Wang AY, Mafra D (2023) Targeting the gut microbiota in kidney disease: the future in renal nutrition and metabolism. J Ren Nutr 33(6S):S30\u2013S39","journal-title":"J Ren Nutr"},{"issue":"1","key":"5061_CR46","first-page":"1363","volume":"8","author":"LM Xie","year":"2015","unstructured":"Xie LM, Ge YY, Huang X, Zhang YQ, Li JX (2015) Effects of fermentable dietary fiber supplementation on oxidative and inflammatory status in hemodialysis patients. Int J Clin Exp Med 8(1):1363\u20131369","journal-title":"Int J Clin Exp Med"},{"key":"5061_CR47","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1039\/C8FO01876F","volume":"9","author":"M Esgalhado","year":"2018","unstructured":"Esgalhado M, Kemp JA, Azevedo R et al (2018) Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial. Food Funct 9:6508\u20136516","journal-title":"Food Funct"},{"key":"5061_CR48","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/hdi.12753","volume":"23","author":"MR Laffin","year":"2019","unstructured":"Laffin MR, Tayebi Khosroshahi H, Park H et al (2019) Amylose resistant starch [HAM-RS2] supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: microbial analysis from a randomized placebo-controlled trial. Hemodial Int 23:343\u2013347","journal-title":"Hemodial Int"},{"issue":"5","key":"5061_CR49","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1159\/000494677","volume":"43","author":"L Jia","year":"2018","unstructured":"Jia L, Jia Q, Yang J, Jia R, Zhang H (2018) Efficacy of probiotics supplementation on chronic kidney disease: a systematic review and meta-analysis. Kidney Blood Press Res 43(5):1623\u20131635","journal-title":"Kidney Blood Press Res"},{"key":"5061_CR50","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1080\/07315724.2017.1334602","volume":"36","author":"B Guida","year":"2017","unstructured":"Guida B, Cataldi M, Memoli A et al (2017) Effect of a shortcourse treatment with synbiotics on plasma p-cresol concentration in kidney transplant recipients. J Am Coll Nutr 36:586\u2013591","journal-title":"J Am Coll Nutr"},{"key":"5061_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2215\/CJN.05240515","volume":"11","author":"M Rossi","year":"2016","unstructured":"Rossi M, Johnson DW, Morrison M et al (2016) Synbiotics Easing Renal Failure by Improving Gut Microbiology [SYNERGY]: a randomized trial. Clin J Am Soc Nephrol 11:223\u2013231","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"5061_CR52","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.jrn.2014.09.008","volume":"25","author":"D Viramontes-Horner","year":"2015","unstructured":"Viramontes-Horner D, Marquez-Sandoval F, Martin-del-Campo F, Vizmanos-Lamotte B, Sandoval-Rodriguez A, Armendariz Borunda J et al (2015) Effect of a symbiotic gel [Lactobacillus acidophilus + Bifidobacterium lactis + inulin] on presence and severity of gastrointestinal symptoms in hemodialysis patients. J Ren Nutr 25(3):284\u2013291","journal-title":"J Ren Nutr"},{"issue":"4","key":"5061_CR53","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1681\/ASN.2016060656","volume":"28","author":"K Sumida","year":"2017","unstructured":"Sumida K, Molnar MZ, Potukuchi PK et al (2017) Constipation and Incident CKD. J Am Soc Nephrol 28(4):1248\u20131258","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"5061_CR54","doi-asserted-by":"publisher","first-page":"428","DOI":"10.5056\/jnm23133","volume":"29","author":"RR Cha","year":"2023","unstructured":"Constipation Research Group of Korean Society of Neurogastroenterology and Motility, Cha RR, Park SY, Camilleri M (2023) Constipation in Patients With Chronic Kidney Disease. J Neurogastroenterol Motil. 29(4):428\u2013435","journal-title":"J Neurogastroenterol Motil."},{"key":"5061_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12120741","author":"C Barba","year":"2020","unstructured":"Barba C, Soulage CO, Caggiano G, Glorieux G, Fouque D, Koppe L (2020) Effects of fecal microbiota transplantation on composition in mice with CKD. Toxins. https:\/\/doi.org\/10.3390\/toxins12120741","journal-title":"Toxins"},{"key":"5061_CR56","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ebiom.2019.05.066","volume":"44","author":"K Wortelboer","year":"2019","unstructured":"Wortelboer K, Nieuwdorp M, Herrema H (2019) Fecal microbiota transplantation beyond Clostridioides difficile infections. EBioMedicine 44:716\u2013729","journal-title":"EBioMedicine"},{"key":"5061_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/nu14122528","author":"J Bian","year":"2022","unstructured":"Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA (2022) Faecal microbiota transplantation and chronic kidney disease. Nutrients. https:\/\/doi.org\/10.3390\/nu14122528","journal-title":"Nutrients"},{"issue":"7","key":"5061_CR58","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1681\/ASN.2014010042","volume":"26","author":"G Schulman","year":"2015","unstructured":"Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Arita K et al (2015) Randomized placebo-controlled EPPIC trials of AST-120 in CKD. J Am Soc Nephrol 26(7):1732\u20131746","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"5061_CR59","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3389\/fmicb.2019.01704","volume":"25","author":"L Gargiullo","year":"2019","unstructured":"Gargiullo L, Del Chierico F, D\u2019Argenio P, Putignani L (2019) Gut microbiota modulation for multidrug-resistant organism decolonization: present and future perspectives. Front Microbiol 25(10):1704","journal-title":"Front Microbiol"},{"issue":"10","key":"5061_CR60","doi-asserted-by":"publisher","first-page":"572912","DOI":"10.3389\/fcimb.2020.572912","volume":"24","author":"J Ramirez","year":"2020","unstructured":"Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, Cohen H (2020) Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol 24(10):572912","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"5061_CR61","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1007\/s12325-020-01458-z","volume":"37","author":"GS Tan","year":"2020","unstructured":"Tan GS, Tay HL, Tan SH, Lee TH, Ng TM, Lye DC (2020) Gut microbiota modulation: implications for infection control and antimicrobial stewardship. Adv Ther 37(10):4054\u20134067","journal-title":"Adv Ther"},{"issue":"8","key":"5061_CR62","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1128\/AAC.00825-16","volume":"60","author":"S Karanika","year":"2016","unstructured":"Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E (2016) Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother 60(8):4840\u20134852","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"5061_CR63","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","volume":"17","author":"D Baur","year":"2017","unstructured":"Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, D\u00f6bele S et al (2017) Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 17(9):990\u2013100","journal-title":"Lancet Infect Dis"},{"key":"5061_CR64","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","volume":"24","author":"AB Roberts","year":"2018","unstructured":"Roberts AB et al (2018) Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med 24:1407\u20131417","journal-title":"Nat Med"},{"issue":"10","key":"5061_CR65","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41581-025-00988-5","volume":"21","author":"PP Bloom","year":"2025","unstructured":"Bloom PP, Garrett WS, Penniston KL, Winkler MH, Hazen SL, Agudelo J, Suryavanshi M, Babiker A, Dodd D, Fischbach MA, Huang KC, Huttenhower C, Joe B, Kalantar-Zadeh K, Knight R, Miller AW, Rabb H, Srivastava A, Tang WHW, Turnbaugh PJ, Walker AW, Wilck N, Xu J, Yang T, Himmelfarb J, Redinbo MR, Wu GD, Woodworth MH, Ackerman AL, Winter S, Rinschen MM, Hassan HA, Biruete A, Anderson AH, Pluznick JL (2025) Microbiota and kidney disease: the road ahead. Nat Rev Nephrol 21(10):702\u2013716","journal-title":"Nat Rev Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05061-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05061-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05061-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:02:19Z","timestamp":1787659339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05061-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5061"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05061-z","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human and animal rights are respected.","order":3,"name":"Ethics","label":"Human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No informed consent is needed.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}